Literature DB >> 23494495

Fluid-attenuated inversion recovery vascular hyperintensities are not visible using 3D CUBE FLAIR sequence.

Jérôme Hodel1, Xavier Leclerc, Mathieu Rodallec, Sophie Gerber, Raphael Blanc, Olivier Outteryck, Samir Benadjaoud, Cécile Rabrait, Mathieu Zuber, Jean-Pierre Pruvo, Marc Zins.   

Abstract

OBJECTIVE: Fluid-attenuated inversion recovery (FLAIR) vascular hyperintensities (FVH), initially described on 2D FLAIR images, are a useful imaging marker in patients with acute ischaemic stroke. We aimed to compare the sensitivity of the 3D CUBE FLAIR sequence with 2D FLAIR for the detection of FVH.
METHODS: Forty-seven consecutive patients admitted for a suspected stroke were explored by 2D and 3D CUBE FLAIR MR sequences at 1.5 and 3 T. Three blinded readers assessed FVH defined as hyperintensities within cerebral arteries. Location of FVH, acute brain infarct and arterial stenosis were also assessed. 2D images were compared with 3D images for the detection of FVH. Agreement between readers was assessed.
RESULTS: Of the 47 patients, 21 FVHs were observed on 2D FLAIR images of 15 patients (11 with acute brain infarct and 11 with an arterial stenosis). No FVH was visualised on 3D CUBE FLAIR images for either proximal or distal locations. Agreement between readers was excellent.
CONCLUSION: FVHs are not visible using 3D CUBE FLAIR images. This study suggests that, in suspected acute ischaemic stroke, the assessment of FVH should only be performed on conventional 2D FLAIR images. KEY POINTS: • Fluid-attenuated inversion recovery (FLAIR) vascular hyperintensities (FVH) are of neuroradiological importance. • FVHs are useful imaging markers in patients with an acute ischaemic stroke. • FVHs are not visible using 3D CUBE FLAIR images. • Assessment of FVH should be performed on conventional 2D FLAIR images.

Entities:  

Mesh:

Year:  2013        PMID: 23494495     DOI: 10.1007/s00330-013-2796-z

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  23 in total

1.  Suppression of cerebrospinal fluid and blood flow artifacts in FLAIR MR imaging with a single-slab three-dimensional pulse sequence: initial experience.

Authors:  D F Kallmes; F K Hui; J P Mugler
Journal:  Radiology       Date:  2001-10       Impact factor: 11.105

2.  Significance of hyperintense vessels on FLAIR MRI in acute stroke.

Authors:  Y Tsushima; K Endo
Journal:  Neurology       Date:  2001-05-08       Impact factor: 9.910

3.  Comparison of flow artifacts between 2D-FLAIR and 3D-FLAIR sequences at 3 T.

Authors:  Shinji Naganawa; Tokiko Koshikawa; Tatsuya Nakamura; Hisashi Kawai; Hiroshi Fukatsu; Takeo Ishigaki; Tomomi Komada; Katsuya Maruyama; Osamu Takizawa
Journal:  Eur Radiol       Date:  2004-06-19       Impact factor: 5.315

4.  Fast spin echo sequences with very long echo trains: design of variable refocusing flip angle schedules and generation of clinical T2 contrast.

Authors:  Reed F Busse; Hari Hariharan; Anthony Vu; Jean H Brittain
Journal:  Magn Reson Med       Date:  2006-05       Impact factor: 4.668

5.  Detection of lesions in multiple sclerosis by 2D FLAIR and single-slab 3D FLAIR sequences at 3.0 T: initial results.

Authors:  Andrea Bink; Melanie Schmitt; Jochen Gaa; John P Mugler; Heinrich Lanfermann; Friedhelm E Zanella
Journal:  Eur Radiol       Date:  2006-01-20       Impact factor: 5.315

Review 6.  Normal MRI appearance and motion-related phenomena of CSF.

Authors:  Christopher Lisanti; Carrie Carlin; Kevin P Banks; David Wang
Journal:  AJR Am J Roentgenol       Date:  2007-03       Impact factor: 3.959

Review 7.  Fluid-attenuated inversion recovery vascular hyperintensities: an important imaging marker for cerebrovascular disease.

Authors:  A Azizyan; N Sanossian; M A Mogensen; D S Liebeskind
Journal:  AJNR Am J Neuroradiol       Date:  2010-11-04       Impact factor: 3.825

8.  Decrease in leptomeningeal ivy sign on fluid-attenuated inversion recovery images after cerebral revascularization in patients with Moyamoya disease.

Authors:  M Kawashima; T Noguchi; Y Takase; Y Nakahara; T Matsushima
Journal:  AJNR Am J Neuroradiol       Date:  2010-05-13       Impact factor: 3.825

9.  Evaluation of hyperintense vessels on FLAIR MRI for the diagnosis of multiple intracerebral arterial stenoses.

Authors:  Daniela Iancu-Gontard; Catherine Oppenheim; Emmanuel Touzé; Eric Méary; Mathieu Zuber; Jean-Louis Mas; Daniel Frédy; Jean-François Meder
Journal:  Stroke       Date:  2003-06-26       Impact factor: 7.914

10.  Three-dimensional fluid attenuated inversion recovery imaging with isotropic resolution and nonselective adiabatic inversion provides improved three-dimensional visualization and cerebrospinal fluid suppression compared to two-dimensional flair at 3 tesla.

Authors:  Gulzar Hameed Chagla; Reed F Busse; Ryan Sydnor; Howard A Rowley; Patrick A Turski
Journal:  Invest Radiol       Date:  2008-08       Impact factor: 6.016

View more
  3 in total

1.  Magnetic resonance post-contrast vascular hyperintensities at 3 T: a new highly sensitive sign of vascular occlusion in acute ischaemic stroke.

Authors:  Loïc Duron; Julien Savatovsky; Michael Obadia; Marie Astrid Metten; Pascal Roux; Raphael Blanc; Jean-Claude Sadik; Sarah Dhundass; Augustin Lecler
Journal:  Eur Radiol       Date:  2018-02-09       Impact factor: 5.315

2.  Comparison of 3D double inversion recovery and 2D STIR FLAIR MR sequences for the imaging of optic neuritis: pilot study.

Authors:  Jérôme Hodel; Olivier Outteryck; Anne-Laure Bocher; Hélène Zéphir; Oriane Lambert; Mohamed Amine Benadjaoud; David Chechin; Jean-Pierre Pruvo; Patrick Vermersch; Xavier Leclerc
Journal:  Eur Radiol       Date:  2014-08-23       Impact factor: 5.315

3.  Vertebral artery dissection associated with familial Mediterranean fever and Behçet's disease.

Authors:  Hidehiro Ishikawa; Akihiro Shindo; Yuichiro Ii; Shoko Sakano; Masaru Asahi; Keita Matsuura; Dai Kishida; Maki Umino; Masayuki Maeda; Hidekazu Tomimoto
Journal:  Ann Clin Transl Neurol       Date:  2019-04-04       Impact factor: 4.511

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.